These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

370 related items for PubMed ID: 11007941

  • 41. Silibinin causes cell cycle arrest and apoptosis in human bladder transitional cell carcinoma cells by regulating CDKI-CDK-cyclin cascade, and caspase 3 and PARP cleavages.
    Tyagi A, Agarwal C, Harrison G, Glode LM, Agarwal R.
    Carcinogenesis; 2004 Sep; 25(9):1711-20. PubMed ID: 15117815
    [Abstract] [Full Text] [Related]

  • 42. p53-independent induction of p21 (WAF1/CIP1), reduction of cyclin B1 and G2/M arrest by the isoflavone genistein in human prostate carcinoma cells.
    Choi YH, Lee WH, Park KY, Zhang L.
    Jpn J Cancer Res; 2000 Feb; 91(2):164-73. PubMed ID: 10761703
    [Abstract] [Full Text] [Related]

  • 43. Soy isoflavones and prostate cancer: a review of molecular mechanisms.
    Mahmoud AM, Yang W, Bosland MC.
    J Steroid Biochem Mol Biol; 2014 Mar; 140():116-32. PubMed ID: 24373791
    [Abstract] [Full Text] [Related]

  • 44. Tea polyphenol (-)-epigallocatechin 3-gallate suppresses heregulin-beta1-induced fatty acid synthase expression in human breast cancer cells by inhibiting phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase cascade signaling.
    Pan MH, Lin CC, Lin JK, Chen WJ.
    J Agric Food Chem; 2007 Jun 27; 55(13):5030-7. PubMed ID: 17539658
    [Abstract] [Full Text] [Related]

  • 45. Epigallocatechin-3-gallate (EGCG) inhibits PC-3 prostate cancer cell proliferation via MEK-independent ERK1/2 activation.
    Albrecht DS, Clubbs EA, Ferruzzi M, Bomser JA.
    Chem Biol Interact; 2008 Jan 10; 171(1):89-95. PubMed ID: 17931610
    [Abstract] [Full Text] [Related]

  • 46. The inhibitory effect of ECG and EGCG dimeric procyanidins on colorectal cancer cells growth is associated with their actions at lipid rafts and the inhibition of the epidermal growth factor receptor signaling.
    Zhu W, Li MC, Wang FR, Mackenzie GG, Oteiza PI.
    Biochem Pharmacol; 2020 May 10; 175():113923. PubMed ID: 32217102
    [Abstract] [Full Text] [Related]

  • 47. Epigallocatechin-3-Gallate suppresses early stage, but not late stage prostate cancer in TRAMP mice: mechanisms of action.
    Harper CE, Patel BB, Wang J, Eltoum IA, Lamartiniere CA.
    Prostate; 2007 Oct 01; 67(14):1576-89. PubMed ID: 17705241
    [Abstract] [Full Text] [Related]

  • 48. Melatonin and (-)-Epigallocatechin-3-Gallate: Partners in Fighting Cancer.
    Zhang L, He Y, Wu X, Zhao G, Zhang K, Yang CS, Reiter RJ, Zhang J.
    Cells; 2019 Jul 19; 8(7):. PubMed ID: 31331008
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Apoptosis of human fibrosarcoma HT-1080 cells by epigallocatechin-3-O-gallate via induction of p53 and caspases as well as suppression of Bcl-2 and phosphorylated nuclear factor-κB.
    Lee MH, Han DW, Hyon SH, Park JC.
    Apoptosis; 2011 Jan 19; 16(1):75-85. PubMed ID: 20963498
    [Abstract] [Full Text] [Related]

  • 51. Antiproliferative and apoptotic effects of silibinin in rat prostate cancer cells.
    Tyagi A, Bhatia N, Condon MS, Bosland MC, Agarwal C, Agarwal R.
    Prostate; 2002 Nov 01; 53(3):211-7. PubMed ID: 12386921
    [Abstract] [Full Text] [Related]

  • 52. A polyphenolic fraction from grape seeds causes irreversible growth inhibition of breast carcinoma MDA-MB468 cells by inhibiting mitogen-activated protein kinases activation and inducing G1 arrest and differentiation.
    Agarwal C, Sharma Y, Zhao J, Agarwal R.
    Clin Cancer Res; 2000 Jul 01; 6(7):2921-30. PubMed ID: 10914742
    [Abstract] [Full Text] [Related]

  • 53. Epigallocatechin 3-O-gallate induces 67 kDa laminin receptor-mediated cell death accompanied by downregulation of ErbB proteins and altered lipid raft clustering in mammary and epidermoid carcinoma cells.
    Mocanu MM, Ganea C, Georgescu L, Váradi T, Shrestha D, Baran I, Katona E, Nagy P, Szöllősi J.
    J Nat Prod; 2014 Feb 28; 77(2):250-7. PubMed ID: 24456004
    [Abstract] [Full Text] [Related]

  • 54. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.
    Thangapazham RL, Singh AK, Sharma A, Warren J, Gaddipati JP, Maheshwari RK.
    Cancer Lett; 2007 Jan 08; 245(1-2):232-41. PubMed ID: 16519995
    [Abstract] [Full Text] [Related]

  • 55. A novel anticancer agent, decursin, induces G1 arrest and apoptosis in human prostate carcinoma cells.
    Yim D, Singh RP, Agarwal C, Lee S, Chi H, Agarwal R.
    Cancer Res; 2005 Feb 01; 65(3):1035-44. PubMed ID: 15705905
    [Abstract] [Full Text] [Related]

  • 56. Lung cancer prevention with (-)-epigallocatechin gallate using monitoring by heterogeneous nuclear ribonucleoprotein B1.
    Fujimoto N, Sueoka N, Sueoka E, Okabe S, Suganuma M, Harada M, Fujiki H.
    Int J Oncol; 2002 Jun 01; 20(6):1233-9. PubMed ID: 12012004
    [Abstract] [Full Text] [Related]

  • 57. Progression of LNCaP prostate tumor cells during androgen deprivation: hormone-independent growth, repression of proliferation by androgen, and role for p27Kip1 in androgen-induced cell cycle arrest.
    Kokontis JM, Hay N, Liao S.
    Mol Endocrinol; 1998 Jul 01; 12(7):941-53. PubMed ID: 9658399
    [Abstract] [Full Text] [Related]

  • 58. The ErbB/HER family of protein-tyrosine kinases and cancer.
    Roskoski R.
    Pharmacol Res; 2014 Jan 01; 79():34-74. PubMed ID: 24269963
    [Abstract] [Full Text] [Related]

  • 59. Chemopreventive agents alters global gene expression pattern: predicting their mode of action and targets.
    Narayanan BA.
    Curr Cancer Drug Targets; 2006 Dec 01; 6(8):711-27. PubMed ID: 17168675
    [Abstract] [Full Text] [Related]

  • 60. Cyclin E-cdk2 activation is associated with cell cycle arrest and inhibition of DNA replication induced by the thymidylate synthase inhibitor Tomudex.
    Yin MB, Guo B, Panadero A, Frank C, Wrzosek C, Slocum HK, Rustum YM.
    Exp Cell Res; 1999 Feb 25; 247(1):189-99. PubMed ID: 10047461
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.